Your browser doesn't support javascript.
loading
The peroxisome proliferator-activated receptor gamma (PPARγ) agonist, rosiglitazone, ameliorates neurofunctional and neuroinflammatory abnormalities in a rat model of Gulf War Illness.
Keledjian, Kaspar; Tsymbalyuk, Orest; Semick, Stephen; Moyer, Mitchell; Negoita, Serban; Kim, Kevin; Ivanova, Svetlana; Gerzanich, Volodymyr; Simard, J Marc.
Affiliation
  • Keledjian K; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, United States of America.
  • Tsymbalyuk O; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, United States of America.
  • Semick S; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, United States of America.
  • Moyer M; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, United States of America.
  • Negoita S; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, United States of America.
  • Kim K; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, United States of America.
  • Ivanova S; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, United States of America.
  • Gerzanich V; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, United States of America.
  • Simard JM; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, United States of America.
PLoS One ; 15(11): e0242427, 2020.
Article in En | MEDLINE | ID: mdl-33186383

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Persian Gulf Syndrome / Rosiglitazone Type of study: Prognostic_studies Limits: Animals Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Persian Gulf Syndrome / Rosiglitazone Type of study: Prognostic_studies Limits: Animals Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States